Stroke patients show higher recovery in MultiStem therapy studied at UH Case Med Center

Stroke patients show higher recovery in MultiStem therapy studied at UH Case Med Center


Data presented by the biotech company Athersys indicate that stroke patients treated by an adult stem cell therapy called MultiStem did significantly better than others who received a placebo one year after treatment. The results are from a Phase 2 study involving clinical sites in the United States and the United Kingdom, including University Hospitals Case Medical Center.



from Biotech News